1. Home
  2. KEN vs AAPG Comparison

KEN vs AAPG Comparison

Compare KEN & AAPG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Kenon Holdings Ltd.

KEN

Kenon Holdings Ltd.

HOLD

Current Price

$61.90

Market Cap

2.7B

Sector

Utilities

ML Signal

HOLD

Logo Ascentage Pharma Group International American Depository Shares

AAPG

Ascentage Pharma Group International American Depository Shares

N/A

Current Price

$30.35

Market Cap

2.8B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
KEN
AAPG
Founded
2014
2009
Country
Singapore
China
Employees
N/A
567
Industry
Electric Utilities: Central
Biotechnology: Pharmaceutical Preparations
Sector
Utilities
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.7B
2.8B
IPO Year
N/A
2025

Fundamental Metrics

Financial Performance
Metric
KEN
AAPG
Price
$61.90
$30.35
Analyst Decision
Strong Buy
Analyst Count
0
5
Target Price
N/A
$48.50
AVG Volume (30 Days)
10.1K
4.4K
Earning Date
12-03-2025
11-19-2025
Dividend Yield
7.83%
N/A
EPS Growth
177.70
N/A
EPS
8.96
N/A
Revenue
$803,304,000.00
$54,524,554.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$368.64
P/E Ratio
$6.69
N/A
Revenue Growth
8.15
N/A
52 Week Low
$27.10
$16.50
52 Week High
$62.88
$48.45

Technical Indicators

Market Signals
Indicator
KEN
AAPG
Relative Strength Index (RSI) 64.28 42.17
Support Level $59.90 $28.50
Resistance Level $62.68 $32.96
Average True Range (ATR) 1.09 0.70
MACD -0.16 -0.05
Stochastic Oscillator 74.19 40.31

Price Performance

Historical Comparison
KEN
AAPG

About KEN Kenon Holdings Ltd.

Kenon Holdings Ltd is a holding company that operates dynamic, growth-oriented businesses. The company's operating segments include OPC Power Plants, CPV Group, and ZIM. It generates maximum revenue from the OPC Power Plants segment, which generates and supplies electricity and energy in Israel. CPV Group is a limited partnership owned by OPC, which generates and supplies electricity and energy in the United States. Geographically, the company generates a majority of its revenue from Israel and the rest from the United States.

About AAPG Ascentage Pharma Group International American Depository Shares

Ascentage Pharma Group International is a clinical-stage biotechnology company engaged in the development and sales of novel small-scale therapies for cancers, hepatitis B virus, or HBV, and certain age-related diseases. It focuses on developing therapies that inhibit protein-protein interactions to restore apoptosis or programmed cell death. The Group has one reportable operating segment, which is discovering, developing, and commercializing therapies to address medical needs in hematological malignancies. The company's geographical segments include the United States and Mainland China.

Share on Social Networks: